Dr. Jack B. Basil, MD

Dr. Basil practices at TriHealth's Good Samaritan Hospital in Cincinnati, Ohio, part of TriHealth.

Dr. Basil's NPI, 1073505525, was assigned on August 19, 2005. Dr. Basil graduated from Ohio State College of Medicine in 1993. Dr. Basil's Ohio license number on file is 35084002.

Dr. Basil's primary practice is TriHealth's Good Samaritan Hospital, at 375 Dixmyth Avenue, Cincinnati, OH 45220 in Hamilton County. The practice phone is (513) 862-2601.

Dr. Basil's primary practice is TriHealth's Good Samaritan Hospital in Cincinnati, Ohio, part of TriHealth. Dr. Basil is also affiliated with Bethesda North Hospital. The medical group on file is TriHealth. Dmand AI also links Dr. Basil to 1 more hospital, 3 group practices and clinics, 3 medical groups, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Basil practices, 8 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Basil's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Basil is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Basil's licenses on file in 4 states: Ohio, Kentucky, Florida and Georgia.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Basil treats.

CMS data shows 358 Medicare services from Dr. Basil across 9 procedure codes in 2024, for 156 Medicare patients. Medicare paid $42,989 for them.

CMS counts 156 Medicare patients who saw Dr. Basil in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Basil's median patient age at 70, with 99% women.

In 2024, Dr. Basil wrote 260 Medicare Part D claims for 79 patients. 86% of them were for generic drugs. CMS names the drug for 129 of them, across 9 drugs with 11 or more claims each, at $59,387 in total drug cost. In 2023, CMS named 97 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Basil for performance year 2024, reported through an alternative payment model (APM). Dr. Basil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of removal of the uterus by Dr. Basil, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Dr. Basil, published from 2009 to 2022. 2010 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Ovarian Neoplasms and Genetic Predisposition to Disease. Dr. Basil has published most often in Hum Mol Genet. Dr. Basil's most frequent co-authors are Stephanie V. Blank, MD, John F. Boggess, MD and Antonis Antoniou, MD.

Dmand AI links Dr. Basil to 10 clinical trials, 4 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Brenner Tumor, Fallopian Tube Diseases and Uterine Cervical Neoplasms. Gynecologic Oncology Group sponsors the most, 6.

CMS Open Payments shows 7 general payments to Dr. Basil from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Nuvasive, Inc. paid the most, $198.

Dmand AI lists 3 awards for Dr. Basil, most recently CMS Stage 1 EHR in 2013.

Dr. Basil graduated from Ohio State College of Medicine in 1993. Dr. Basil is a member of American College of Obstetricians and Gynecologists and ACS.

Dr. Basil is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.